• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞通过 STAT3 信号促进肝癌的肿瘤进展。

Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.

机构信息

Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Pathobiology. 2013;80(3):146-54. doi: 10.1159/000346196. Epub 2013 Jan 25.

DOI:10.1159/000346196
PMID:23364389
Abstract

OBJECTIVE

Signal transducer and activator of transcription 3 (STAT3) is activated in hepatocellular carcinoma (HCC), and tumor-associated macrophage plays an important role in tumor progression. Therefore, we examined STAT3 activation, cytokine expression and infiltration of tumor-associated macrophages in resected HCCs as well as the alteration of cell growth and migration by cytokine stimulation in HCC cell lines.

METHODS

Immunohistochemical staining of phosphorylated STAT3 (pSTAT3), CD163, interleukin (IL)-6, Ki-67 and Bcl-XL was performed for 101 cases of resected HCC, and correlations between pSTAT3 staining and clinicopathological findings were analyzed. In HCC cell lines (PLC/PRF/5 and Huh7), cell proliferation and migration by IL-6 stimulation and S3I-201 (STAT3 inhibitor) treatment were analyzed.

RESULTS

In HCC specimens, the pSTAT3-positive group showed high levels of α-fetoprotein (p = 0.0276), large tumor size (p = 0.0092), frequent intrahepatic metastasis (p = 0.0214), high Ki-67 (p = 0.0002) and Bcl-XL (p = 0.0001), poor prognosis (p = 0.0234), and high recurrence rate (p = 0.0003). CD163-positive cells were frequently observed in the pSTAT3-positive group (p = 0.0013). In two HCC cell lines, IL-6 stimulation promoted cell proliferation and migration via the STAT3 phosphorylation, and S3I-201 inhibited this activation.

CONCLUSIONS

STAT3 activation was correlated with aggressive behavior of HCC and may be mediated via tumor-associated macrophage. We expect that STAT3 signaling and tumor-associated macrophages can be attractive therapeutic targets in HCC patients.

摘要

目的

信号转导子和转录激活子 3(STAT3)在肝细胞癌(HCC)中被激活,肿瘤相关巨噬细胞在肿瘤进展中发挥重要作用。因此,我们研究了在切除的 HCC 中 STAT3 的激活、细胞因子的表达和肿瘤相关巨噬细胞的浸润,以及细胞因子刺激对 HCC 细胞系中细胞生长和迁移的改变。

方法

对 101 例切除的 HCC 进行磷酸化 STAT3(pSTAT3)、CD163、白细胞介素(IL)-6、Ki-67 和 Bcl-XL 的免疫组织化学染色,并分析 pSTAT3 染色与临床病理特征的相关性。在 HCC 细胞系(PLC/PRF/5 和 Huh7)中,分析了 IL-6 刺激和 S3I-201(STAT3 抑制剂)处理对细胞增殖和迁移的影响。

结果

在 HCC 标本中,pSTAT3 阳性组的甲胎蛋白(AFP)水平较高(p = 0.0276),肿瘤较大(p = 0.0092),肝内转移频繁(p = 0.0214),Ki-67 和 Bcl-XL 高表达(p = 0.0002 和 p = 0.0001),预后不良(p = 0.0234),复发率高(p = 0.0003)。pSTAT3 阳性组中经常观察到 CD163 阳性细胞(p = 0.0013)。在两种 HCC 细胞系中,IL-6 刺激通过 STAT3 磷酸化促进细胞增殖和迁移,而 S3I-201 抑制这种激活。

结论

STAT3 的激活与 HCC 的侵袭性行为相关,可能通过肿瘤相关巨噬细胞介导。我们期望 STAT3 信号通路和肿瘤相关巨噬细胞能成为 HCC 患者有吸引力的治疗靶点。

相似文献

1
Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.肿瘤相关巨噬细胞通过 STAT3 信号促进肝癌的肿瘤进展。
Pathobiology. 2013;80(3):146-54. doi: 10.1159/000346196. Epub 2013 Jan 25.
2
Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.磷酸化信号转导及转录激活因子3(酪氨酸705)表达的改变与肝细胞癌的组织学分级及肿瘤内微血管密度相关。
J Clin Pathol. 2007 Jun;60(6):642-8. doi: 10.1136/jcp.2006.036970. Epub 2006 Aug 10.
3
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.微小 RNA-26a 通过靶向白细胞介素 6-Stat3 通路抑制人肝癌的肿瘤生长和转移。
Hepatology. 2013 Jul;58(1):158-70. doi: 10.1002/hep.26305. Epub 2013 Jun 5.
4
Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.靶向信号转导和转录激活因子3的反义寡核苷酸对人肝癌生长和转移的抑制作用
Clin Cancer Res. 2006 Dec 1;12(23):7140-8. doi: 10.1158/1078-0432.CCR-06-0484.
5
Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.AMPK 激活的预后意义和二甲双胍在肝细胞癌中的治疗效果。
Clin Cancer Res. 2013 Oct 1;19(19):5372-80. doi: 10.1158/1078-0432.CCR-13-0203. Epub 2013 Aug 13.
6
Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.干扰素调节因子(IRF)-1 和 IRF-2 与 HCC 的预后和肿瘤侵袭有关。
Ann Surg Oncol. 2013 Jan;20(1):267-76. doi: 10.1245/s10434-012-2487-z. Epub 2012 Jul 18.
7
CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.CADPE 通过阻断 IL-6 诱导的 STAT3 激活来抑制肝癌细胞中环素 D1 的表达。
Anticancer Res. 2010 Feb;30(2):481-8.
8
Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.肿瘤相关巨噬细胞产生白细胞介素6并通过信号转导和转录激活因子3(STAT3)发出信号,以促进人肝癌干细胞的扩增。
Gastroenterology. 2014 Dec;147(6):1393-404. doi: 10.1053/j.gastro.2014.08.039. Epub 2014 Aug 30.
9
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.和厚朴酚通过蛋白酪氨酸磷酸酶 SHP-1 抑制信号转导子和转录激活子 3 信号、肝癌细胞的增殖和存活。
J Cell Physiol. 2012 May;227(5):2184-95. doi: 10.1002/jcp.22954.
10
Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.信号转导子和转录激活子 3 可用于区分肝癌和肝硬化。
Chin Med J (Engl). 2017 Nov 20;130(22):2686-2690. doi: 10.4103/0366-6999.218016.

引用本文的文献

1
Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis.全身炎症反应指数在宫颈癌中的预后价值:一项Meta分析
Future Sci OA. 2025 Dec;11(1):2526990. doi: 10.1080/20565623.2025.2526990. Epub 2025 Jul 6.
2
Decoding the therapeutic mechanism of in hepatocellular carcinoma: network pharmacology, molecular docking, and LC-MS QTOF insights.解析[具体物质或疗法]在肝细胞癌中的治疗机制:网络药理学、分子对接及液相色谱-质谱联用飞行时间质谱分析见解
Front Pharmacol. 2025 Jun 17;16:1582374. doi: 10.3389/fphar.2025.1582374. eCollection 2025.
3
Prognostic and clinicopathological impact of systemic inflammation response index (SIRI) on patients with esophageal cancer: a meta-analysis.
全身炎症反应指数(SIRI)对食管癌患者的预后及临床病理影响:一项荟萃分析
Syst Rev. 2025 May 9;14(1):104. doi: 10.1186/s13643-025-02847-7.
4
Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages.姜黄素通过调节肿瘤相关巨噬细胞抑制卵巢癌的恶性行为。
Med Oncol. 2025 Apr 5;42(5):151. doi: 10.1007/s12032-025-02682-9.
5
Biomimetic mineralized DCPA/ anti-CD47 containing thermo-sensitive injectable hydrogel for bone-metastatic prostate cancer treatment.用于骨转移性前列腺癌治疗的含仿生矿化磷酸二钙/抗CD47的热敏可注射水凝胶
Mater Today Bio. 2025 Feb 11;31:101573. doi: 10.1016/j.mtbio.2025.101573. eCollection 2025 Apr.
6
Unlocking the potential of : A breakthrough in liver cancer treatment Wnt/β-catenin pathway modulation.释放:肝癌治疗的突破——Wnt/β-连环蛋白信号通路调控的潜力
World J Gastroenterol. 2025 Jan 28;31(4):99397. doi: 10.3748/wjg.v31.i4.99397.
7
Prognostic and clinicopathological role of pretreatment systemic inflammation response index (SIRI) in gastric cancer: a systematic review and meta-analysis.治疗前全身炎症反应指数(SIRI)在胃癌中的预后及临床病理作用:一项系统评价和荟萃分析
World J Surg Oncol. 2024 Dec 20;22(1):333. doi: 10.1186/s12957-024-03602-3.
8
Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy.肿瘤相关巨噬细胞在肝细胞癌中的作用:影响、机制与治疗。
Front Immunol. 2024 Aug 7;15:1429812. doi: 10.3389/fimmu.2024.1429812. eCollection 2024.
9
inhibits M2 tumor-associated macrophage polarization Wnt/β-catenin pathway modulation to suppress liver cancer.抑制 M2 肿瘤相关巨噬细胞极化,调节 Wnt/β-catenin 通路,抑制肝癌。
World J Gastroenterol. 2024 Aug 7;30(29):3511-3533. doi: 10.3748/wjg.v30.i29.3511.
10
Systemic inflammation enhances metastatic growth in a syngeneic neuroblastoma mouse model.系统性炎症增强了同源神经母细胞瘤小鼠模型中的转移生长。
Pediatr Surg Int. 2024 Jul 17;40(1):195. doi: 10.1007/s00383-024-05788-9.